New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
06:41 EDTIPXLImpax price target raised to $35 from $27 at Piper Jaffray
Piper Jaffray raised its price target for Impax shares to $35 saying it sees more upside potential than downside risk even with the absence of a resolution of the FDA warning letter related to the Hayward manufacturing facility. Piper reiterates an Overweight rating on the stock.
News For IPXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 8, 2014
11:30 EDTIPXLLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
07:29 EDTIPXLUBS to hold investor trip
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use